Fusion Antibodies PLC

LSE:FAB (UK)   Ordinary Shares
£ 0.04 (+3.85%) Apr 12
At Loss
P/B:
1.69
Market Cap:
£ 3.86M ($ 4.81M)
Enterprise V:
£ 3.42M ($ 4.26M)
Volume:
1.65M
Avg Vol (2M):
1.32M
Volume:
1.65M
At Loss

Business Description

Description
Fusion Antibodies PLC offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development. It is engaged in the research, development, and manufacturing of recombinant proteins, particularly in the areas of cancer and infectious diseases. Its services include antibody sequencing, antibody humanization, stable cell line development, monoclonal antibody production, and transient protein expression. Geographically company generates the majority of its revenue from North America.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 10.36
Equity-to-Asset 0.71
Debt-to-Equity 0.03
Debt-to-EBITDA -0.02
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -5.36
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 58.37
9-Day RSI 56.22
14-Day RSI 53.17
6-1 Month Momentum % -37.6
12-1 Month Momentum % -89.87

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.26
Quick Ratio 2.32
Cash Ratio 0.88
Days Inventory 115.78
Days Sales Outstanding 157.42
Days Payable 148.78

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.6
Shareholder Yield % -39.66

Financials (Next Earnings Date:2024-09-27 Est.)

LSE:FAB's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Fusion Antibodies PLC Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil £) 1.579
EPS (TTM) (£) -0.086
Beta 2.83
Volatility % 108.8
14-Day RSI 53.17
14-Day ATR (£) 0.003092
20-Day SMA (£) 0.0389
12-1 Month Momentum % -89.87
52-Week Range (£) 0.0302 - 0.5
Shares Outstanding (Mil) 95.37

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Fusion Antibodies PLC Filings

Filing Date Document Date Form
No Filing Data

Fusion Antibodies PLC Stock Events

Financials Calendars
Event Date Price(£)
No Event Data

Fusion Antibodies PLC Frequently Asked Questions

What is Fusion Antibodies PLC(LSE:FAB)'s stock price today?
The current price of LSE:FAB is £0.04. The 52 week high of LSE:FAB is £0.50 and 52 week low is £0.03.
When is next earnings date of Fusion Antibodies PLC(LSE:FAB)?
The next earnings date of Fusion Antibodies PLC(LSE:FAB) is 2024-09-27 Est..
Does Fusion Antibodies PLC(LSE:FAB) pay dividends? If so, how much?
Fusion Antibodies PLC(LSE:FAB) does not pay dividend.

Press Release

Subject Date
No Press Release